Answers are grounded in this paper and cite their sources.
Cholecystectomy has been associated with an increased risk of colorectal cancer (CRC), although the underlying mechanisms remain unclear. We investigated bile acid composition in hepatic and gallbladder bile and examined the effects of bile samples and individual bile acids on non-malignant FHC colonic epithelial cells and Caco-2 and HCT-116 CRC cells. Cell proliferation, adhesion, migration, invasion, and colony formation were assessed, alongside potential signaling mechanisms involved in the response to taurocholic acid (TCA). Hepatic and gallbladder bile differed markedly in bile acid composition, and their effects on cell proliferation varied by cell line. TCA, taurochenodeoxycholic acid (TCDCA), and deoxycholic acid (DCA) modulated proliferation and other tumor-associated cellular properties in a bile acid-, cell line-, and endpoint-dependent manner. TCA increased sphingosine-1-phosphate receptor 2 (S1PR2) protein expression in Caco-2 and HCT-116 cells. Pharmacological inhibition of S1PR2, EGFR, AKT, MEK1/2, or COX-2 reduced proliferation in TCA-treated cells, although these inhibitors also affected basal proliferation. These findings demonstrate that bile acids can directly modulate colorectal cell behavior and suggest that S1PR2-associated signaling may contribute to cellular responses to TCA, warranting further mechanistic investigation.
No takes yet. Share an insight, caveat, or question.
Yosef et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: